NAD+ salvage is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-01-21. Where a claim depends on a specific study, the study is described rather than over-claimed.
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide found in the cells of many organisms, including bacteria, plants, and mammals. Its structure consists of a nicotinamide ring attached to a ribose-phosphate group. NMN functions as an intermediate in the NAD+ salvage pathway, a recycling route that regenerates nicotinamide adenine dinucleotide. The enzyme nicotinamide phosphoribosyltransferase produces NMN from nicotinamide and phosphoribosyl pyrophosphate. A second enzyme, NMN adenylyltransferase, then converts NMN into NAD+.
Dietary sources of NMN include small amounts in certain vegetables, fruits, and other foods, although exact values vary by sample and method. Endogenous NMN concentrations are tightly regulated and often low, making measurement in blood or tissues technically demanding. After oral intake, NMN is thought to be rapidly metabolized in the intestine and liver, and intact NMN may not reach all tissues at high levels. Some rodent studies report increases in tissue NAD+ after oral NMN, while human data remain limited and sometimes rely on blood NAD+ metabolites rather than direct tissue measures.
Research on NMN has focused on aging, metabolic regulation, exercise capacity, and insulin sensitivity, but findings are preliminary. Many human trials are small, short in duration, and use different endpoints, which complicates comparison across studies. No national regulator has approved NMN as a therapeutic drug for any indication. In some countries it is sold as a supplement or research chemical, while other jurisdictions have questioned its status under food or supplement laws. Claims about extending human lifespan or reversing aging are not supported by established clinical evidence.
The term NMN commonly refers to the beta isomer, in which the nicotinamide group is attached to the ribose through a beta-glycosidic bond. Commercial material may be supplied as the free acid or as a salt, such as a sodium salt, which affects molecular weight and water solubility. Related compounds include nicotinamide riboside and NAD+ itself, but these are distinct molecules with different formulas and cellular handling. Laboratory research often uses the beta form because it matches the naturally occurring configuration found in biological systems.
Small amounts of NMN occur in some foods, including certain vegetables, fruits, and animal products, though the quantities are generally low and variable. Human cells also synthesize NMN internally from nicotinamide and other precursors. Research interest increased after studies examined whether raising NAD+ levels affects metabolism and aging-related pathways in animals. Evidence in humans remains limited and mixed for many outcomes, and questions about effective absorption, tissue delivery, and long-term effects are still open. Regulatory status differs by country, with some markets treating NMN as a supplement ingredient and others restricting its sale.
Nicotinamide mononucleotide, usually shortened to NMN, is a naturally occurring nucleotide. Its structure consists of a nicotinamide base linked to a ribose sugar that carries a phosphate group. In cells, NMN serves as an intermediate in the salvage pathway that produces nicotinamide adenine dinucleotide, or NAD+. Because NAD+ participates in many oxidation-reduction reactions, NMN sits near central metabolic processes. The compound is not a drug in most jurisdictions and is discussed mainly in biochemistry and nutrition research.
| Property | Value | Notes |
|---|---|---|
| Chemical name | Nicotinamide mononucleotide | Nucleotide intermediate in NAD+ salvage pathway |
| Common abbreviation | NMN | Also written as β-NMN |
| Molecular formula | C11H15N2O8P | Uncharged parent form |
| Molar mass | 334.22 g/mol | Calculated from formula |
| CAS Registry Number | 1094-61-7 | For β-nicotinamide mononucleotide |
NMN is present in small amounts in some foods, including certain vegetables, fruits, and animal products, but food content varies widely and is not well standardized. In laboratory research, NMN is used as a tool compound to study NAD+ metabolism, mitochondrial function, and cellular stress responses. Animal studies have reported changes in NAD+ levels and various physiological measures after NMN administration, but species differences and study designs limit direct extrapolation to humans. Human trials have largely focused on safety, tolerability, and pharmacokinetics, with fewer studies examining clinical endpoints.
Nicotinamide mononucleotide, commonly abbreviated NMN, is a naturally occurring nucleotide. Its structure consists of a nicotinamide ring attached to a ribose sugar that carries a phosphate group. The molecular formula is C11H15N2O8P, and the molar mass is about 334.22 grams per mole. In cells, NMN is an intermediate in the salvage pathway that recycles nicotinamide to maintain NAD+ levels. It is not the same compound as NAD+, although it is a direct precursor in one enzymatic step.
Inside cells, the enzyme nicotinamide phosphoribosyltransferase, or NAMPT, converts nicotinamide and a ribose-phosphate donor into NMN. A second enzyme, NMN adenylyltransferase, then converts NMN into NAD+. NAD+ participates in redox reactions and serves as a substrate for signaling enzymes such as sirtuins, PARPs, and CD38. Because NAD+ levels tend to decline with age in many organisms, NMN has drawn interest as a possible way to influence that decline. Whether oral NMN reliably raises NAD+ in human tissues, and whether any such change modifies disease risk, remain open research questions.
In the salvage pathway, NMN is generated from nicotinamide and 5-phosphoribosyl-1-pyrophosphate by the enzyme nicotinamide phosphoribosyltransferase. A second route produces NMN from nicotinamide riboside through phosphorylation by nicotinamide riboside kinases. NMN is then converted to NAD+ by nicotinamide mononucleotide adenylyltransferases, often called NMNAT enzymes. This stepwise route allows cells to recycle nicotinamide and maintain NAD+ levels under changing metabolic conditions. The relative contribution of each route varies by tissue, species, and physiological state, and it remains an active area of research.
Research on NMN has expanded because NAD+ concentrations decline with age in some tissues and because NAD+ participates in energy metabolism, DNA repair, and signaling. Animal studies have reported changes in NAD+ levels after NMN administration, but human data are more limited and often focus on safety, pharmacokinetics, and biomarker changes. Questions remain about oral absorption, tissue distribution, and whether changes in blood NAD+ reflect changes inside specific organs. NMN is not an approved drug, and claims about its clinical effects should be distinguished from established biochemical findings.
=== Elimination of suprabony fibrous and firm pockets === Gingivectomy is the primary treatment method available in reducing the pocket depths of patients with periodontitis and suprabony pockets. In a retrospective comparison between different treatment approach to periodontitis management based on the initial and final gingival health, conventional gingivectomy was proven to be more successful in reducing pocket depths and inflammation compared to non-surgical treatments in pockets measured 3mm or more. Removal of suprabony deep pockets will allow better visibility and access for the removal of calculus. As a result, this provides a suitable environment for the healing of the gingiva and the physiological contour of the gingiva to be restored.
In July 2018, Tim Hortons announced that they would open 1,500 stores in China. The first of these opened on February 26, 2019, in Huangpu District, Shanghai. By December 31, 2024, the number of stores nationwide has reached 1,022, covering 82 cities. The first Tim Hortons location in Thailand opened on January 18, 2020, at Samyan Mitrtown Mall in Bangkok through a franchise partnership with Thailand-based WeEat Co. As of January 2021, there are 10 locations operating in the country. The first two Tim Hortons locations in India opened on August 11, 2022, in New Delhi and Gurugram, followed by a third location, in New Delhi, on August 31, 2022. On February 11, 2023, Tim Hortons opened four locations in DHA, Lahore, and Gulberg, and announced to open more locations in other major cities of Pakistan. In January 2024, Tim Hortons opened another store in Pakistan, this time in Islamabad. In 2023, Japanese conglomerate Marubeni Corporation announced that they were planning to open a Tim Hortons location in Singapore, Malaysia, and to open another in Indonesia, in 2024. The location in Singapore officially opened at VivoCity on November 17, 2023. On August 30, 2024, Tim Hortons opened its first ever Tim's Signature at 313@Somerset, Singapore which sells more upmarket coffee options, such as single-origin and filter brews. As of December 2025, Tim Hortons has 15 outlets in Singapore including Tim's Signature. In 2026, Tim Hortons Singapore became halal-certified.
==== Worker safety ==== A rule from 2024 had been scheduled to go into effect in Spring of 2025 lowering the allowable silica dust from 100 to 50 micrograms per cubic meter of air averaged over an 8-hour shift, with 50 being the standard already enforced by OSHA in other industries. However, industry lawsuits delayed the rule in April 2025, and the Trump administration did not energetically defend the new standard. In addition, a group of seven Republicans in the U.S. House led by Tim Walberg (MI-5) signed a letter to the Mine Safety and Health Administration saying the new rule ignored cheaper solutions such as job rotation. In 2018, National Institute for Occupational Safety and Health reported that approximately one in five coal miners with at least 25 years' experience in central Appalachia had black lung disease. However, among 11,000 workers who sought chest X-rays from 2020 to 2025, approximately 55% had some form of black lung. In April 2026, the administration proposed eliminating the Chemical Safety Board, cutting the Occupational Safety and Health Administration budget by 7.5%, and cutting the Mine Safety and Health Administration budget by 10%.
=== Malaria vaccine === In 2014, GSK applied for regulatory approval for the first malaria vaccine. Malaria is responsible for over 650,000 deaths annually, mainly in Africa. Known as RTS,S, the vaccine was developed as a joint project with the PATH vaccines initiative and the Bill and Melinda Gates Foundation. The company has committed to making the vaccine available in developing countries for five per cent above the cost of production. As of 2013, RTS,S, which uses GSK's proprietary AS01 adjuvant, was being examined in a Phase 3 trial in eight African countries. PATH reported that "[i]n the 12-month period following vaccination, RTS,S conferred approximately 50% protection from clinical Plasmodium falciparum disease in children aged 5-17 months, and approximately 30% protection in children aged 6-12 weeks when administered in conjunction with Expanded Program for Immunization (EPI) vaccines." In 2014, Glaxo said it had spent more than US$350 million and expected to spend an additional US$260 million before seeking regulatory approval.
Sources: en.wikipedia.org
=== Procedure (Standard Assay, 20-150 μg protein; 200-1500 μg/mL) === Prepare a series of standards diluted with 0.15 M NaCl to final concentrations of 0 (blank = No protein), 250, 500, 750 and 1500 μg/mL. Also prepare serial dilutions of the unknown sample to be measured. Add 100 μL of each of the above to a separate test tube (or spectrophotometer tube if using a Spectronic 20). Add 5.0 mL of Coomassie Blue to each tube and mix by vortex, or inversion. Adjust the spectrophotometer to a wavelength of 595 nm, using the tube which contains no protein (blank). Wait 5 minutes and read each of the standards and each of the samples at 595 nm wavelength. Plot the absorbance of the standards vs. their concentration. Compute the extinction coefficient and calculate the concentrations of the unknown samples.
=== Fibronectin glomerulopathy === Fibronectin glomerulopathy is a rare form of glomerulopathy characterised by enlarged glomeruli with deposits in the mesangium and subendothelial space. The deposits have been shown to be fibronectin. This condition is inherited in an autosomal dominant fashion. About 40% of cases are due to mutations in the fibronectin (FN1) gene located on chromosome 2 (2q34).
=== Cold fusion === 208Pb(48Ca,xn)256−xNo (x=1,2,3,4) This cold fusion reaction was first studied in 1979 at Flerov Laboratory of Nuclear Reactions (FLNR). Further work in 1988 at GSI measured EC and SF branchings in 254No. In 1989, the FLNR used the reaction to measure SF decay characteristics for the two isomers of 254No. The measurement of the 2n excitation function was reported in 2001 by Yuri Oganessian at the FLNR. Patin et al. at the LBNL reported in 2002 the synthesis of 255–251No in the 1-4n exit channels and measured further decay data for these isotopes. The reaction has recently been used at Jyväskylän Yliopisto Fysiikan Laitos (JYFL) using the RITU set-up to study K-isomerism in 254No. The scientists were able to measure two K-isomers with half-lives of 275 ms and 198 s, respectively. They were assigned to 8− and 16+ K-isomeric levels. The reaction was used in 2004–5 at the FLNR to study the spectroscopy of 255–253No. The team were able to confirm an isomeric level in 253No with a half-life of 43.5 s.
AI programs use knowledge to answer questions intelligently and make deductions about real-world facts. Formal knowledge representation and knowledge engineering use symbols to represent words, concepts and things in the world. A knowledge base is a body of knowledge represented in a form that can be used by a program. An ontology is the set of objects, relations, concepts, and properties used by a particular domain of knowledge. Formal knowledge has been studied extensively since the 1970s and researchers have developed formalisms for a wide variety of difficult domains. The symbolic approach has difficulty with several problems: the breadth of commonsense knowledge (the set of atomic facts the average person knows is enormous), the sub-symbolic form of most commonsense knowledge (much of what people know is not represented as "facts" or "statements" they can express verbally), and knowledge acquisition (the problem of obtaining knowledge for AI applications). Large language models (and some other AI programs developed since 2012) do not require explicit, symbolic knowledge. They acquire knowledge by being trained on the combined text of millions of books and billions of websites. Modern AI can also learn about a domain by running experiments (as when AlphaZero learns game strategy by playing against itself). Machine learning solves the problems of general knowledge, commonsense knowledge and knowledge acquisition, however, this approach has struggled with accurate recall and valid reasoning.
On 5 May, a national uprising began spontaneously in Prague, and the newly formed Czech National Council (cs) almost immediately assumed leadership of the revolt. Over 1,600 barricades were erected throughout the city, and some 30,000 Czech men and women battled for three days against 40,000 German troops backed by tanks, aircraft and artillery. On 8 May, the German Wehrmacht capitulated; Soviet troops arrived on 9 May.
Sources: en.wikipedia.org
=== Anaesthesia === A common regimen for general anesthesia for the house mouse is ketamine (in the dose of 100 mg per kg body weight) plus xylazine (in the dose of 5–10 mg per kg), injected by the intraperitoneal route. It has a duration of effect of about 30 minutes.
=== Loeys–Dietz syndrome === TGF-β signaling is also disturbed in Loeys–Dietz syndrome which can be caused by mutations in TGF-β proteins, TGF-β receptor proteins, or TGF-β signaling second messengers like SMAD3.
α, catalytic domain, has two paralogous versions: α1 and α2 which are encoded from PRKAA1 and PRKAA2 β, regulatory domain, has two paralogous versions: β1 and β2 which are encoded from PRKAB1 and PRKAB2 γ, regulatory domain, has three paralogous versions: γ1, γ2, and γ3 which are encoded from PRKAG1, PRKAG2, and PRKAG3 In human skeletal muscle, the preferred form is α2β2γ1. But in the human liver, the most abundant form is α1β2γ1.
The dispersal of Indo-Europeans from a proposed homeland in the Pontic–Caspian steppe according to the Kurgan hypothesis is suggested to be linked to the spread of the R haplogroup subclade, R1a1, into Europe. R1a1 may also reflect the arrival of the Indo-Aryans into northern India. The Y-chromosomal lineage L could potentially reflect an earlier patrilingual dispersal of the proposed Elamo-Dravidian family emanating from a region in modern-day Iran. Austroasiatic speakers show a high frequency of the O2a haplogroup subclade. For example, Munda speakers in north and northeast India show high frequencies of O2a, not found in their regional neighbours who speak languages other than Austroasiatic, whilst their mtDNA haplogroups seem to be those frequent in their region independent of language affinity. A population genetic study of 23 Han Chinese populations has shown that the Han expansion southward during the sinification of what today is southern China was predominantly male-biased and is an uncontroversial example of the Father Tongue hypothesis. It has also been suggested that Bantu and other Niger-Congo languages correlate well with Y-chromosomal haplogroups. The spread of Afroasiatic languages has been linked to the expansion of E1b1b haplogroup.
Sources: en.wikipedia.org
NMN is nicotinamide mononucleotide, a nucleotide intermediate in the NAD+ salvage pathway. Cells use it to help regenerate NAD+, a coenzyme involved in energy metabolism and cellular signaling. It is present naturally in many organisms and is also produced synthetically for research and consumer products.
NMN is the immediate precursor to NAD+ in the salvage pathway. The enzyme NMN adenylyltransferase adds an adenylate group to NMN to form NAD+. Because NAD+ levels decline with age in some tissues, researchers study whether raising NMN availability can influence NAD+ metabolism.
No. Human evidence is limited, and no regulatory agency has approved NMN for treating or preventing aging. Some trials measure NAD+ metabolites or metabolic markers, but their results do not establish a clinical benefit. Larger, longer studies with standardized endpoints are needed.
NMN stands for nicotinamide mononucleotide. It is a nucleotide composed of nicotinamide, ribose, and phosphate. In cells, it is an intermediate in NAD+ biosynthesis.